Genesis Study 17+
Eclat srl
-
- Free
iPhone Screenshots
Description
A 12-month randomised, double-blind, controlled, international multicentre trial comparing changes in cigarette consumption after switching to high or low nicotine strength e-cigarettes in smokers with Schizophrenia spectrum disorders. This will be a multicenter, 12-months prospective trial, utilizing a randomized, double-blind, 2-arm parallel, switching design to compare effectiveness, tolerability, acceptability, and pattern of use between high (JUUL 5% nicotine) and low nicotine strength devices (JUUL 1.5% nicotine) in adult smokers with schizophrenia spectrum disorders. The study will take place at 5 sites: 1 in the UK (London) and possibly 4 in Italy.
DISCLAIMER : To seek a doctor’s advice in addition to using this app and before making any medical decisions.
We are using HealthKit to get step count to display on Health Dairy screen and graph on Report screen. We also send daily step count to server with questionary for study purpose.
What’s New
Version 1.0.6
We've squashed a few thorny bugs in this update.
App Privacy
The developer, Eclat srl, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.
Data Not Collected
The developer does not collect any data from this app.
Privacy practices may vary based on, for example, the features you use or your age. Learn More
Information
- Provider
- Eclat srl
- Size
- 42.8 MB
- Category
- Medical
- Compatibility
-
- iPhone
- Requires iOS 11.0 or later.
- iPod touch
- Requires iOS 11.0 or later.
- Apple Vision
- Requires visionOS 1.0 or later.
- Languages
-
English
- Age Rating
- 17+ Infrequent/Mild Medical/Treatment Information Unrestricted Web Access Infrequent/Mild Alcohol, Tobacco, or Drug Use or References
- Copyright
- © @coehar.org 2021
- Price
- Free